GB0506001D0 - Novel use - Google Patents

Novel use

Info

Publication number
GB0506001D0
GB0506001D0 GB0506001A GB0506001A GB0506001D0 GB 0506001 D0 GB0506001 D0 GB 0506001D0 GB 0506001 A GB0506001 A GB 0506001A GB 0506001 A GB0506001 A GB 0506001A GB 0506001 D0 GB0506001 D0 GB 0506001D0
Authority
GB
United Kingdom
Prior art keywords
novel use
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0506001A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GB0506001A priority Critical patent/GB0506001D0/en
Publication of GB0506001D0 publication Critical patent/GB0506001D0/en
Priority to TW095109703A priority patent/TW200700078A/en
Priority to CNA2006800175565A priority patent/CN101180078A/en
Priority to JP2008502346A priority patent/JP2008534467A/en
Priority to ARP060101106A priority patent/AR053833A1/en
Priority to BRPI0609772-3A priority patent/BRPI0609772A2/en
Priority to EP06723805.5A priority patent/EP1861120B1/en
Priority to US11/909,388 priority patent/US20080171063A1/en
Priority to PL06723805.5T priority patent/PL1861120T3/en
Priority to PCT/EP2006/002837 priority patent/WO2006100110A1/en
Priority to BRPI0609519-4A priority patent/BRPI0609519A2/en
Priority to MX2007011775A priority patent/MX2007011775A/en
Priority to SG201001631-9A priority patent/SG160386A1/en
Priority to CN2006800175620A priority patent/CN101180076B/en
Priority to NZ561823A priority patent/NZ561823A/en
Priority to PE2006000311A priority patent/PE20061300A1/en
Priority to CA2603180A priority patent/CA2603180C/en
Priority to EA200701786A priority patent/EA011419B1/en
Priority to DK06723805.5T priority patent/DK1861120T3/en
Priority to KR1020137034497A priority patent/KR101916787B1/en
Priority to CA002602456A priority patent/CA2602456A1/en
Priority to MX2007011756A priority patent/MX2007011756A/en
Priority to ES06723805.5T priority patent/ES2585810T3/en
Priority to US11/909,414 priority patent/US20090081253A1/en
Priority to AU2006226459A priority patent/AU2006226459A1/en
Priority to BRPI0609516A priority patent/BRPI0609516B8/en
Priority to US11/909,351 priority patent/US20080181911A1/en
Priority to ARP060101107A priority patent/AR054020A1/en
Priority to EP06723807A priority patent/EP1861122A1/en
Priority to SI200632082A priority patent/SI1861120T1/en
Priority to KR1020077024388A priority patent/KR20070116652A/en
Priority to AU2006226543A priority patent/AU2006226543B2/en
Priority to JP2008502345A priority patent/JP5770414B2/en
Priority to HUE06723805A priority patent/HUE027837T2/en
Priority to PCT/EP2006/002838 priority patent/WO2006100111A1/en
Priority to KR1020077024380A priority patent/KR20070116650A/en
Priority to JP2008502344A priority patent/JP5869744B2/en
Priority to TW095109709A priority patent/TW200700079A/en
Priority to KR1020167014235A priority patent/KR20160064249A/en
Priority to TW095109708A priority patent/TW200722101A/en
Priority to ARP060101108A priority patent/AR052625A1/en
Priority to PCT/EP2006/002836 priority patent/WO2006100109A1/en
Priority to KR1020077024383A priority patent/KR20070116651A/en
Priority to EA200701785A priority patent/EA011393B1/en
Priority to EP11173265A priority patent/EP2397153A1/en
Priority to AU2006226458A priority patent/AU2006226458B2/en
Priority to MX2007011748A priority patent/MX2007011748A/en
Priority to PT67238055T priority patent/PT1861120T/en
Priority to PE2006000312A priority patent/PE20061428A1/en
Priority to EP06723806A priority patent/EP1863529A1/en
Priority to NZ561822A priority patent/NZ561822A/en
Priority to EA200701787A priority patent/EA200701787A1/en
Priority to CA2601022A priority patent/CA2601022C/en
Priority to PE2006000334A priority patent/PE20061387A1/en
Priority to IL185901A priority patent/IL185901A0/en
Priority to IL185897A priority patent/IL185897A/en
Priority to IL185906A priority patent/IL185906A0/en
Priority to NO20074635A priority patent/NO20074635L/en
Priority to NO20074638A priority patent/NO20074638L/en
Priority to ZA200707915A priority patent/ZA200707915B/en
Priority to ZA200707917A priority patent/ZA200707917B/en
Priority to MA30238A priority patent/MA30298B1/en
Priority to MA30240A priority patent/MA29715B1/en
Priority to MA30241A priority patent/MA29342B1/en
Priority to NO20074930A priority patent/NO20074930L/en
Priority to US12/148,095 priority patent/US20090028903A1/en
Priority to US12/951,857 priority patent/US20110123568A1/en
Priority to US13/096,180 priority patent/US20110287054A1/en
Priority to JP2014016254A priority patent/JP2014129359A/en
Priority to US14/465,055 priority patent/US9730999B2/en
Priority to HRP20160816TT priority patent/HRP20160816T1/en
Priority to CY20161100772T priority patent/CY1117874T1/en
Ceased legal-status Critical Current

Links

GB0506001A 2005-03-23 2005-03-23 Novel use Ceased GB0506001D0 (en)

Priority Applications (72)

Application Number Priority Date Filing Date Title
GB0506001A GB0506001D0 (en) 2005-03-23 2005-03-23 Novel use
TW095109703A TW200700078A (en) 2005-03-23 2006-03-21 Novel use
CNA2006800175565A CN101180078A (en) 2005-03-23 2006-03-21 Combination
JP2008502346A JP2008534467A (en) 2005-03-23 2006-03-21 Composition
ARP060101106A AR053833A1 (en) 2005-03-23 2006-03-21 IMMUNOGENETIC COMPOSITION
BRPI0609772-3A BRPI0609772A2 (en) 2005-03-23 2006-03-21 multivalent influenza immunogenic composition, method for producing an influenza immunogenic composition for a pandemic situation, and uses of an influenza virus or antigenic preparation thereof and an oil-in-water emulsion adjuvant, and an antigen or antigenic preparation of a first strain of influenza
EP06723805.5A EP1861120B1 (en) 2005-03-23 2006-03-21 Use of an influenza virus and an oil-in-water emulsion adjuvant to induce cd4 t-cell and/or improved b-memory cell response
US11/909,388 US20080171063A1 (en) 2005-03-23 2006-03-21 Novel Composition
PL06723805.5T PL1861120T3 (en) 2005-03-23 2006-03-21 Use of an influenza virus and an oil-in-water emulsion adjuvant to induce cd4 t-cell and/or improved b-memory cell response
PCT/EP2006/002837 WO2006100110A1 (en) 2005-03-23 2006-03-21 Novel composition
BRPI0609519-4A BRPI0609519A2 (en) 2005-03-23 2006-03-21 composition, use of a composition, method of vaccination, use of an antigen, and method for preparation of an immunogenic composition
MX2007011775A MX2007011775A (en) 2005-03-23 2006-03-21 Composition.
SG201001631-9A SG160386A1 (en) 2005-03-23 2006-03-21 Novel composition
CN2006800175620A CN101180076B (en) 2005-03-23 2006-03-21 Use of an influenza virus an oil-in-water emulsion adjuvant to induce CD4 T-cell and/or improved B-memory cell response
NZ561823A NZ561823A (en) 2005-03-23 2006-03-21 Use of an influenza virus and an oil-in-water emulsion adjuvant to induce cd4 t-cell and/or improved b-memory cell response
PE2006000311A PE20061300A1 (en) 2005-03-23 2006-03-21 MULTIVALENT IMMUNOGENIC COMPOSITIONS INCLUDING AN ANTIGEN OF THE FLU OR ANTIGENIC PREPARATION IN COMBINATION WITH AN ADJUVANT OF EMULSION OF OIL IN WATER
CA2603180A CA2603180C (en) 2005-03-23 2006-03-21 Influenza vaccine compositions and method for immunization against influenza disease
EA200701786A EA011419B1 (en) 2005-03-23 2006-03-21 Multivalent influenza immunogenic composition
DK06723805.5T DK1861120T3 (en) 2005-03-23 2006-03-21 Use of an influenza virus and an oil-in-water emulsion adjuvant to induce CD 4 T cell and / or enhanced B memory cell response
KR1020137034497A KR101916787B1 (en) 2005-03-23 2006-03-21 Use of an influenza virus and an oil-in-water emulsion adjuvant to induce cd4 t-cell and/or improved b-memory cell response
CA002602456A CA2602456A1 (en) 2005-03-23 2006-03-21 Composition
MX2007011756A MX2007011756A (en) 2005-03-23 2006-03-21 Use of an influenza virus an oil-in-water emulsion adjuvant to induce cd4 t-cell and/or improved b-memory cell response.
ES06723805.5T ES2585810T3 (en) 2005-03-23 2006-03-21 Use of a flu virus and an oil-in-water emulsion adjuvant to induce a CD4 T cell response and / or an improved memory B cell response
US11/909,414 US20090081253A1 (en) 2005-03-23 2006-03-21 Composition
AU2006226459A AU2006226459A1 (en) 2005-03-23 2006-03-21 Composition
BRPI0609516A BRPI0609516B8 (en) 2005-03-23 2006-03-21 use of an influenza virus or antigenic preparation thereof
US11/909,351 US20080181911A1 (en) 2005-03-23 2006-03-21 Use Of An Influenza Virus, An Oil-In-Water Emulsion Adjuvant, To Induce Cd4 T-Cell And/Or Improved B-Memory Cell Response
ARP060101107A AR054020A1 (en) 2005-03-23 2006-03-21 NEW USE
EP06723807A EP1861122A1 (en) 2005-03-23 2006-03-21 Composition
SI200632082A SI1861120T1 (en) 2005-03-23 2006-03-21 Use of an influenza virus and an oil-in-water emulsion adjuvant to induce cd4 t-cell and/or improved b-memory cell response
KR1020077024388A KR20070116652A (en) 2005-03-23 2006-03-21 Use of an influenza virus and an oil-in-water emulsion adjuvant to induce cd4 t-cell and/or improved b-memory cell response
AU2006226543A AU2006226543B2 (en) 2005-03-23 2006-03-21 Use of an influenza virus an oil-in-water emulsion adjuvant to induce CD4 T-cell and/or improved B-memory cell response
JP2008502345A JP5770414B2 (en) 2005-03-23 2006-03-21 New composition
HUE06723805A HUE027837T2 (en) 2005-03-23 2006-03-21 Use of an influenza virus and an oil-in-water emulsion adjuvant to induce cd4 t-cell and/or improved b-memory cell response
PCT/EP2006/002838 WO2006100111A1 (en) 2005-03-23 2006-03-21 Composition
KR1020077024380A KR20070116650A (en) 2005-03-23 2006-03-21 Novel composition
JP2008502344A JP5869744B2 (en) 2005-03-23 2006-03-21 Use of influenza virus and oil-in-water emulsion adjuvants to induce CD4 T cell and / or improved memory B cell responses
TW095109709A TW200700079A (en) 2005-03-23 2006-03-21 Composition
KR1020167014235A KR20160064249A (en) 2005-03-23 2006-03-21 Use of an influenza virus and an oil-in-water emulsion adjuvant to induce cd4 t-cell and/or improved b-memory cell response
TW095109708A TW200722101A (en) 2005-03-23 2006-03-21 Novel composition
ARP060101108A AR052625A1 (en) 2005-03-23 2006-03-21 NEW COMPOSITION
PCT/EP2006/002836 WO2006100109A1 (en) 2005-03-23 2006-03-21 Use of an influenza virus an oil-in-water emulsion adjuvant to induce cd4 t-cell and/or improved b-memory cell response
KR1020077024383A KR20070116651A (en) 2005-03-23 2006-03-21 Composition
EA200701785A EA011393B1 (en) 2005-03-23 2006-03-21 Use of an influenza virus based on an oil-in-water emulsion adjuvant for inducing cd4 t cell immune response based on b-memory cell response
EP11173265A EP2397153A1 (en) 2005-03-23 2006-03-21 Novel composition
AU2006226458A AU2006226458B2 (en) 2005-03-23 2006-03-21 Novel composition
MX2007011748A MX2007011748A (en) 2005-03-23 2006-03-21 Novel composition.
PT67238055T PT1861120T (en) 2005-03-23 2006-03-21 Use of an influenza virus and an oil-in-water emulsion adjuvant to induce cd4 t-cell and/or improved b-memory cell response
PE2006000312A PE20061428A1 (en) 2005-03-23 2006-03-21 VACCINE FORMULATION INCLUDING AN OIL EMULSION ADJUVANT IN WATER AND 3D-MPL
EP06723806A EP1863529A1 (en) 2005-03-23 2006-03-21 Novel composition
NZ561822A NZ561822A (en) 2005-03-23 2006-03-21 Multivalent influenza virus vaccine
EA200701787A EA200701787A1 (en) 2005-03-23 2006-03-21 IMMUNE COMPOSITION, METHOD FOR ITS MANUFACTURE, ITS APPLICATION AND VACCINATION METHOD
CA2601022A CA2601022C (en) 2005-03-23 2006-03-21 Use of an influenza virus an oil-in-water emulsion adjuvant to induce cd4 t-cell and/or improved b-memory cell response
PE2006000334A PE20061387A1 (en) 2005-03-23 2006-03-23 IMMUNOGENIC COMPOSITIONS OF THE FLU VIRUS
IL185901A IL185901A0 (en) 2005-03-23 2007-09-11 Novel composition
IL185897A IL185897A (en) 2005-03-23 2007-09-11 Use of an influenza virus or antigenic preparation thereof from a first influenza strain and an oil-in- water emulsion adjuvant in the preparation of an immunogenic composition for protection against influenza infections caused by a variant influenza strain wherein said oil-in-water emulsion comprises a squalene, alpha-tocopherol and an emulsifying agent
IL185906A IL185906A0 (en) 2005-03-23 2007-09-11 Composition
NO20074635A NO20074635L (en) 2005-03-23 2007-09-12 Use of an influenza virus as an oil-in-water emulsion adjuvant to induce CD4 T cell and / or enhanced B memory cell response
NO20074638A NO20074638L (en) 2005-03-23 2007-09-12 New composition
ZA200707915A ZA200707915B (en) 2005-03-23 2007-09-14 Use of an influenza virus and an oil-in-water emulsion adjuvant to induce CD4 T-cell and/or improved B-memory cell response
ZA200707917A ZA200707917B (en) 2005-03-23 2007-09-14 Composition
MA30238A MA30298B1 (en) 2005-03-23 2007-09-24 COMPOSITION
MA30240A MA29715B1 (en) 2005-03-23 2007-09-24 USE OF INFLUENZA-LIKE INFLUENZA-LIKE VIRUS AND EMULSION-LIKE ADJUVANT TO INDUCE CD-4 T CELL AND / OR IMPROVE RESPONSE OF MEMORY B CELL
MA30241A MA29342B1 (en) 2005-03-23 2007-09-24 NEW COMPOSITION
NO20074930A NO20074930L (en) 2005-03-23 2007-09-28 Mixture
US12/148,095 US20090028903A1 (en) 2005-03-23 2008-04-16 Novel use
US12/951,857 US20110123568A1 (en) 2005-03-23 2010-11-22 Novel use
US13/096,180 US20110287054A1 (en) 2005-03-23 2011-04-28 Multivalent adjuvanted influenza virus compositions
JP2014016254A JP2014129359A (en) 2005-03-23 2014-01-31 Use of influenza virus and oil-in-water emulsion adjuvant for inducing cd4 t-cell response and/or improved b cell memory response
US14/465,055 US9730999B2 (en) 2005-03-23 2014-08-21 Adjuvanted influenza virus compositions
HRP20160816TT HRP20160816T1 (en) 2005-03-23 2016-07-07 Use of an influenza virus and an oil-in-water emulsion adjuvant to induce cd4 t-cell and/or improved b-memory cell response
CY20161100772T CY1117874T1 (en) 2005-03-23 2016-08-05 USE OF AN INFLUENCE VIRUS AND OIL-IN-WATER Immunosuppressive Emulsion to Induce Response to CD4 T-Cells and / or VELIMON KIRIM

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0506001A GB0506001D0 (en) 2005-03-23 2005-03-23 Novel use

Publications (1)

Publication Number Publication Date
GB0506001D0 true GB0506001D0 (en) 2005-04-27

Family

ID=34531764

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0506001A Ceased GB0506001D0 (en) 2005-03-23 2005-03-23 Novel use

Country Status (3)

Country Link
CN (2) CN101180076B (en)
GB (1) GB0506001D0 (en)
ZA (2) ZA200707915B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2464341B1 (en) * 2009-08-12 2022-07-06 Sublimity Therapeutics Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
WO2014180999A1 (en) * 2013-05-10 2014-11-13 Novartis Ag Avoiding narcolepsy risk in influenza vaccines
CN104338129B (en) * 2013-07-26 2017-05-24 中国科学院上海巴斯德研究所 Application of Rapamycin as vaccine adjuvant and preparation method thereof
CU20170173A7 (en) * 2017-12-27 2019-11-04 Ct Inmunologia Molecular NANO-PARTICLES CONTAINING GM3 GANGLIOSIDE AS IMMUNOMODULATORS
CN110917136B (en) * 2019-11-25 2021-08-24 中国人民解放军陆军军医大学 Anti-tumor nano-emulsion adjuvant nasal mucosa vaccine and preparation method thereof
CN116987201B (en) * 2023-09-27 2023-12-08 贝格探索(成都)科技有限公司 Multimeric recombinant protein for regulating and controlling reproductive capacity of mammal, preparation method and application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines

Also Published As

Publication number Publication date
CN101180076A (en) 2008-05-14
ZA200707917B (en) 2009-05-27
ZA200707915B (en) 2010-05-26
CN101180076B (en) 2012-10-24
CN101180078A (en) 2008-05-14

Similar Documents

Publication Publication Date Title
AP2108A (en) Novel biphenylsulfonamides
GB0522715D0 (en) New use
GB0505954D0 (en) Novel use
GB0520176D0 (en) Use
GB0511190D0 (en) Use
GB0506001D0 (en) Novel use
EP1846443A4 (en) Novel use
GB0506800D0 (en) New uses
GB0526031D0 (en) Use
GB0502250D0 (en) Use
GB0526552D0 (en) New use
GB0526032D0 (en) Use
GB0510207D0 (en) Novel combination
GB0508924D0 (en) New use
GB0510589D0 (en) Novel use
GB0615597D0 (en) Novel use
GB0525456D0 (en) Novel use
GB0521273D0 (en) Novel use
GB0521271D0 (en) Novel use
GB0516653D0 (en) Novel use
GB0516650D0 (en) Novel use
GB0510592D0 (en) Novel use
GB0510591D0 (en) Novel use
GB0506015D0 (en) Novel use
GB0506000D0 (en) Novel use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)